Business Context and Reporting Period
Northrop Grumman Corporation is a global aerospace and defense technology company serving primarily the U.S. Department of Defense, intelligence community, and international customers. This unaudited Form 10-Q covers the three months ended March 31, 2023, compared with the corresponding 2022 period. The interim financial statements were reviewed by Deloitte & Touche and prepared under U.S. GAAP.
Key Financial Metrics
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Sales | $9.301 billion | $8.797 billion | Up 6% |
| Operating income | $947 million | $897 million | Up 6% |
| Operating margin | 10.2% | 10.2% | Flat |
| Net earnings | $842 million | $955 million | Down 12% |
| Diluted EPS | $5.50 | $6.10 | Down 10% |
| Effective tax rate | 15.6% | 16.5% | Down 0.9 points |
| Cash used in operating activities | $702 million | $488 million | Higher use of $214 million |
| Capital expenditures | $309 million | $244 million | Up 27% |
| Adjusted free cash flow | $(1.011) billion | $(732) million | Higher use of $279 million |
At March 31, 2023, cash and cash equivalents were $2.495 billion. Long-term debt was $13.770 billion, compared with $11.805 billion at December 31, 2022, following the issuance of $2.0 billion of senior notes in February 2023. No commercial paper or credit-facility borrowings were outstanding, and the company was in compliance with its debt covenants.
Backlog was $77.5 billion, including $39.3 billion funded and $38.2 billion unfunded. Management expects approximately 40% of backlog to convert to revenue within 12 months and 65% within 24 months. First-quarter net awards were $8.0 billion.
Material Changes Versus the Prior Comparable Period
- Sales growth was led by Space Systems, up 17% to $3.350 billion, Defense Systems, up 7% to $1.376 billion, and Mission Systems, up 3% to $2.563 billion. Aeronautics Systems sales declined 7% to $2.515 billion.
- Segment operating income declined 3% to $1.002 billion, and segment margin declined to 10.8% from 11.8%. Higher projected pension costs on fixed-price contracts reduced segment operating income by approximately $50 million.
- Net earnings declined primarily because the non-operating FAS pension benefit decreased by $244 million. This was partly offset by higher operating income, improved marketable-securities returns, and the lower tax rate.
- Aggregate favorable net contract estimate-at-completion adjustments were $46 million, compared with $173 million in the prior-year quarter. The 2022 period included a $67 million favorable adjustment on the B-21 engineering, manufacturing, and development phase; no material individual adjustment was recorded in Q1 2023.
- Operating cash flow was pressured by working-capital outflows, particularly vendor-payment timing, accounts receivable, inventory, and other liabilities. Management stated that cash flow is generally weighted toward the second half of the year.
- The company repurchased $723 million of common stock, including a $500 million accelerated share repurchase agreement, and paid $270 million of dividends. The quarterly dividend was $1.73 per share.
Outlook, Commentary, Risks, and Unusual Items
Management did not provide a clear formal revenue, earnings, or cash-flow guidance range in the filing. Management expects continued demand supported by heightened global security concerns, including requirements in Europe and the Pacific region, but also expects inflation, supply-chain disruption, labor constraints, and other macroeconomic pressures to adversely affect the business during 2023.
- Management estimates that the current IRC Section 174 tax-amortization rules will reduce 2023 operating cash flow by approximately $720 million. Potential legislative changes could alter this impact.
- The company believes one or more of the five B-21 low-rate initial production options could be performed at a loss. The estimated aggregate possible loss range is $0 to $1.2 billion; no loss was recorded because management did not believe a loss was probable.
- The company faces ongoing Bethpage, New York environmental remediation. Accrued environmental costs were $570 million, with $357 million of reasonably possible future costs in excess of accrued amounts and $498 million of deferred costs expected to be recoverable through government-contract overhead charges.
- A DOJ criminal subpoena and civil investigative demand concern financial and cost accounting controls related to interest-rate assumptions used in CAS pension expense. The company cannot predict the outcome, and states that the matter could materially affect financial position, results, or cash flows.
- Unrecognized tax benefits were approximately $1.7 billion, including $572 million related to IRC Section 451(b). An unfavorable resolution could materially affect future cash flows.
- The company expects to complete the sale of a minority investment later in 2023, subject to approvals and closing conditions, and currently expects a pre-tax gain of approximately $100 million.
- Other risks include dependence on U.S. government funding, potential debt-ceiling-related payment delays, contract cost growth, bid protests, regulatory and legal proceedings, cybersecurity threats, supplier performance, and geopolitical developments.
Investor Verification Priorities
- Verify the conversion of the $77.5 billion backlog into funded orders, revenue, and cash, particularly within Space Systems and the B-21 program.
- Monitor B-21 low-rate initial production cost estimates and whether any potential loss becomes probable and reportable.
- Assess operating-cash-flow recovery in subsequent quarters and the effect of Section 174 tax payments, working-capital timing, and progress-payment changes.
- Review leverage, debt maturities, interest expense, and the use of proceeds from the February 2023 senior-note issuance.
- Track developments in the DOJ and DCMA CAS pension matter, tax examinations, Bethpage remediation, and related litigation.
- Determine whether the anticipated $100 million investment-sale gain is completed and recognized.